WHO statement on AstraZeneca COVID-19 vaccine safety signals
- Details
- Category: Business

First participants dosed in Phase 1 study evaluating mRNA-1283, Moderna's next generation COVID-19 vaccine
- Details
- Category: Business

European Commission purchases additional 150 million doses of COVID-19 vaccine Moderna
- Details
- Category: Business

U.S. government purchases additional 100 million doses of Moderna's COVID-19 vaccine
- Details
- Category: Business

CureVac initiates rolling submission with European Medicines Agency for COVID-19 vaccine candidate, CVnCoV
- Details
- Category: Business

Sinovac receives conditional marketing authorization in China for its COVID-19 vaccine
- Details
- Category: Business
Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced that the China National Medical Products Administration (NMPA) has granted a conditional marketing authorization (CMA) to Sinovac for CoronaVac, Sinovac’s COVID-19 vaccine in individuals aged 18 and above.
Pfizer and BioNTech publish data from in vitro studies demonstrating COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants
- Details
- Category: Business

More Pharma News ...
- Efficacy of Sputnik V against COVID-19 was reported at 91.6%
- In vitro studies demonstrate Pfizer and BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with key mutations present in U.K. and South African variants
- Valneva commences manufacturing of its inactivated, adjuvanted COVID-19 vaccine, completes Phase 1/2 study recruitment
- Pfizer and BioNTech publish results of study showing COVID-19 vaccine elicits antibodies that neutralize pseudovirus bearing the SARS-CoV-2 U.K. strain spike protein
- Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
- An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission
- European Commission authorizes COVID-19 vaccine Moderna in Europe